Earum Pharmaceuticals Ltd

About the Company:

Earum Pharmaceuticals is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products.

Company offers around 125 pharmaceutical formulation products, of which around 24 products are marketed by the company under own brandname, the manufacturing of which is outsourced to third parties.

Apart from pharmaceutical formulation products, Company also deals in trading of active pharmaceutical ingredients (API’s) such as Levofloxacin Hemihdrate IP Albendazol IP, Amoxicillin Trihydrate IP etc.

Currently company has presence in Indian States such as Gujarat, Maharashtra, Chhattisgarh, Uttar Pradesh, Mizoram, Andhra Pradesh, Rajasthan, Madhya Pradesh,
Manipur, Assam, Meghalaya, Kerala, Telangana etc.


Pharmaceutical Formulation products such as:

anti-biotic drugs
anti-malarial drugs
anti-allergic & anti cold drugs
analgesic/ anti-pyretic & anti inflammatory drugs
dermatology products
cerebral activator drugs
neurological drugs
gastro intestinal drugs
steroids, gynecology drugs
calcium, multivitamins
anti-oxidants and injections.



Management Team:

  1. Mr. Bhumishth Narendrabhai Patel (Designation: Chairman & Managing Director)
  2. Mrs. Payal Bhumishth Patel (Designation: Whole Time Director)


Objectives of the Issue:

  • To meet Working Capital requirements
  • General Corporate Purpose
  • To meet issue expenses


Financials of the Company:

(in Crores) FY 16 FY 17 FY 18 31st Dec 18
Revenue 18.63 23.69 35.84 34.50
Net Profit 0.097 0.15 0.85 0.86


Valuation of Peer Group Companies:

Company Name Face Value EPS PE Ratio RoNW NAV
Earum Pharmaceuticals Ltd 10 3.50 10.28 20.34% 136.46
Vaishali Pharma Ltd 10 1.41 30.96 3.87% 25.83


IPO Details:

Details Info
Issue Opens on 21st June 2019
Issue Closes on:. 26th June 2019
Issue Price Rs.36
Face Value Rs.10
Minimum Lot 3000
Minimum Investment Rs.1,08,000
Issue Constitutes 29.96%
Issue Size Rs.6.65 cr
Market Cap Rs.22.20 cr
Listing at BSE SME
Equity Shares Offered (fresh) 18,48,000
Equity Shares Prior to the Issue 43,19,910
Equity Shares after the Issue 61,67,910


IPO Valuation Parameters:

Earnings Per Share (EPS) Price To Earnings ratio (PE) Return on Net Worth (RoNW) Net Asset Value (NAV)
3.50 10.28 20.34% 136.46


Check IPO Allotment Status:

Bigshare Website (Click on the below Link)



Company Contact Info:
Earum Pharmaceuticals Ltd
G1, Ground Floor, V R Complex, Near Sanathal Cross Road,
SP Ring Road, Sanathal. Ahmedabad – 382210, Gujarat, India
Tel. No.+91-79-48402525
E-mail: info@earumpharma.com
Website: https://www.earumpharma.com


IPO Registrar Info:
Address:-1st Floor, Bharat Tin Works Building,
Opp. Vasant Oasis, Makwana Road,
Marol, Andheri East, Mumbai – 400059
Tel No.:+91-022-62638200
Fax No.: +91-022-62638299
Website: www.bigshareonline.com


Lead Manager to the Issue:
904,A Wing, Naman Midtown, Senapati Bapat Marg,
Elphinstone Road, Lower Parel,
Mumbai-400013, India
Tel. No.: +91- 022- 49060000
Fax No.: +91- 022- 22625991
Email: ib@hemsecurities.com
Website: www.hemsecurities.com